Nondystrophic myotonias (NDM) are muscle disorders caused by genetic abnormalities in certain muscle cell membrane proteins. Individuals with NDM experience limited muscle relaxation, which causes pain, weakness, and impaired physical activity. The purpose of this study is to better characterize the clinical features and symptoms of NDM.
Nondystrophic myotonias are muscle disorders caused by abnormal muscle cell membrane proteins that affect the control of muscle fiber contraction. These disorders are extremely rare, and little is known about how to best treat the various subtypes of NDM. The purpose of this study is to characterize the clinical features and symptoms of NDM as well as to pair this data with specific NDM subtypes. In turn, this may lead to the development of improved treatments. The study will also establish clinical endpoints for use in future studies. This multi-center observational study will involve both a cross-sectional data analysis and a prospective longitudinal analysis. Participants will initially attend a one-day outpatient study visit. Various baseline measurements will be collected, including demographics, medical history, and quality of life measures. Blood samples will be taken to evaluate laboratory values and genetic factors. Participants will undergo manual muscle testing (MMT), clinical myotonia assessments, and functional movement assessments. Routine nerve conduction studies and electromyography (EMG) will also be performed in order to test for the presence of myotonia in specific muscles. Annual follow-up evaluations will occur 1 and 2 years following the first study visit.
Study Type
OBSERVATIONAL
Enrollment
94
University of Kansas Medical Center, Department of Neurology
Kansas City, Kansas, United States
Brigham & Women's Hospital, Department of Neurology
Boston, Massachusetts, United States
University of Rochester School of Medicine and Dentistry, Department of Neurology
Rochester, New York, United States
University of Texas Southwestern Medical Center
Examine the frequency applicable events related to Nondystrophic Myotonia
We will measure by an interactive voice response to measure stiffness, pain, weakness, and fatigue.
Time frame: Baseline - 3 yrs
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dallas, Texas, United States
London Health Sciences Centre, University Hospital
London, Ontario, Canada
Center for Neuromuscular Disease, Institute of Neurology and National Hospital for Neurology
London, United Kingdom